The NSW Government has extended its program to provide free Rapid Antigen Tests (RAT) for COVID-19 for another three months until October 31.
Free RAT kits are available to eligible Commonwealth Concession Card holders and the program has been expanded to include people acquiring tests through the Federal Government’s Concessional Access Program.
Ten free RAT kits are available to people with disability, immuno-compromised people and their carers as well as holders of eligible Commonwealth Concession Cards such as Pension Concession Card, Commonwealth Seniors Health Card, Low Income Health Care Card and Department of Veterans’ Affairs Gold, White or Orange Cards.
These test kits are available at various locations across the Central Coast: Kariong Neighbourhood Centre at 10 Langford Dr; Central Coast Community Council, 1 Bay Village Rd, Bateau Bay; Green Point-Terrigal Community Services, 96 Kooland Rd, Green Point; San Remo Neighbourhood Centre at 28 Brava Ave; Toukley Neighbourhood Centre in Heador St; Coast Community Connections, 93 McMasters Rd, Woy Woy; Gosford Regional Community Services, 147 Maidens Brush Rd, Wyoming; Yerin Aboriginal Health Services, 37 Alison Rd, Wyong; and Central Coast Family Support Services, 21 Old Penang Rd, Kariong.
Parliamentary Secretary for the Central Coast, Adam Crouch, said the NSW Government was committed to making sure no one was left behind and ensuring vulnerable communities had the support they needed through winter.
“There is no need to rush or panic about whether or not you will be able to access tests, we have enough tests to support you,” he said.
“The NSW Government has already made millions of Rapid Antigen Tests available to vulnerable communities, including multicultural communities, people with disability and their carers, homelessness services, social housing tenants, and children and young people in out-of-home care.
“We want to keep the pressure off the most vulnerable as much as possible, and the expansion of this program is a key way for the NSW Government to do that.
“Access to these tests is also important for these groups as early diagnosis and treatment are vital given the higher risks for these cohorts to COVID-19,” Crouch said.